IP Library Granted Patent US 11,033,517
Granted Patent B2
US 11,033,517 · App. 16/888,678 · Granted Jun 15, 2021

Materials and methods for controlling infections

Inventors: Carolyn L. Twomey (Lawrenceville, GA); Gareth Clarke (Lawrenceville, GA); Samuel Zaidspiner (Lawrenceville, GA)
Assignee: Innovation Technologies, Inc.
A61K31/155A61F13/00063A61K9/0019A61K9/0043A61K9/0073A61K9/0085A61K9/08A61K31/191A61K45/06A61L15/44A61L17/005A61L27/54A61L29/08A61L29/16A61L31/08A61L31/16A61M25/0017A61K2300/00A61L2300/206
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,033,517
App. No.
16/888,678
Granted
Jun 15, 2021
Kind
B2
Abstract

The subject invention provides materials methods for reducing infections in subjects. The materials methods utilize chlorhexidine, which has been found to be surprisingly non-toxic. The lack of toxicity facilitates the use of chlorhexidine in contexts that were not previously thought to be possible.

Claims (8)

1. A method for reducing an infection at a site in a human subject, wherein said method comprises administering to the site an aqueous solution that comprises chlorhexidine at a concentration of 1% or less, and wherein the site is a respiratory tract and wherein said administration of chlorhexidine reduces the infection in the respiratory tract, and wherein the composition is administered to the respiratory tract via inhalation of vapor and/or an aerosol.

2. The method of claim 1 , wherein the concentration of chlorhexidine is about 0.05% or less.

3. The method of claim 1 , wherein the chlorhexidine is chlorhexidine gluconate.

4. The method of claim 1 , wherein the infection is a bacterial or viral infection.

5. The method of claim 1 , wherein, prior to the administration of the chlorhexidine, the subject has been diagnosed with a viral or bacterial infection.

6. The method of claim 5 , wherein the infection is a bacterial infection.

7. The method of claim 5 , wherein the infection is a viral infection.

8. The method of claim 5 , wherein the chlorhexidine is chlorhexidine gluconate.

Assignments (2)
SECURITY INTEREST Recorded Aug 21, 2024
From: INNOVATION TECHNOLOGIES, INC.
To: OXFORD FINANCE LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 068360/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2020
From: TWOMEY, CAROLYN L.; CLARKE, GARETH; ZAIDSPINER, SAMUEL
To: INNOVATION TECHNOLOGIES, INC.
Reel/Frame 052797/0715 →
Continuity (9)
Continuation 16449361 · Jun 22, 2019
Continuation 15942471 · Mar 31, 2018
Continuation 15803255 · Nov 3, 2017
Continuation 15803279 · Nov 3, 2017
Continuation 15173089 · Jun 3, 2016
Continuation 15168176 · May 30, 2016
Continuation 14568925 · Dec 12, 2014
Provisional Application 61915281 · Dec 12, 2013
Related Publication 20200289435A1 · Sep 17, 2020